Because the increasing prevalence of atrial fibrillation imposes significant financial and clinical burdens, efficient healthcare delivery is required to improve outcomes and reduce associated costs.
Vidal Essebag, MD, PhD
Advertisement
Articles by Vidal Essebag, MD, PhD
Advertisement
Latest Updated Articles
- Economic Burden of Atrial Fibrillation: Implications for Intervention
Published: April 4th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Current and Emerging BCMAxCD3 Bispecifics
3
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
4
Same Pathway, Different Profiles: Clinical Considerations for Alpelisib, Capivasertib, and Inavolisib
5
